Free Trial
ASX:CBL

Control Bionics (CBL) Stock Price, News & Analysis

About Control Bionics Stock (ASX:CBL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$12.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Control Bionics and its competitors with MarketBeat's FREE daily newsletter.

CBL Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
Trading
Current Symbol
ASX:CBL
CIK
N/A
Fax
N/A
Employees
460
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.91 million
Net Margins
-110.52%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$5.35 million
Price / Cash Flow
N/A
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$12.60 million
Optionable
Not Optionable
Beta
0.15
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:CBL) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners